Clinical Outcomes and Inflammatory Responses of the Frequent Exacerbator in Pulmonary Rehabilitation: A Prospective Cohort Study

References

• Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13–64. doi:10.1164/rccm.201309-1634ST.
   PubMed Web of Science ®Google Scholar
• Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006;173(12):1390–1413. doi:10.1164/rccm.200508-1211ST.
   PubMed Web of Science ®Google Scholar
• Spruit MA, Augustin IML, Vanfleteren LE, et al. Differential response to pulmonary rehabilitation in COPD: multidimensional profiling. Eur Respir J. 2015;46(6):1625–1635. doi:10.1183/13993003.00350-2015.
   PubMed Web of Science ®Google Scholar
• Ambrosino N, Clini EM. Response to pulmonary rehabilitation: toward personalised programmes? Eur Respir J. 2015;46(6):1538–1540. doi:10.1183/13993003.01125-2015.
   PubMed Web of Science ®Google Scholar
• Kaul V, Farokhi MR, Megally M. Pulmonary rehabilitation, an update: clinical phenotypes and effect of comorbidities and echocardiographic abnormalities. Am J Respir Crit Care Med. 2018;197(4):517–519. doi:10.1164/rccm.201703-0528RR.
   PubMedGoogle Scholar
• Hassan M, Mourad S, Abdel Wahab NH, et al. Effect of comorbidities on response to pulmonary rehabilitation in patients with chronic obstructive pulmonary disease. Egypt J Chest Dis Tuberc. 2016;65(1):63–69. doi:10.1016/j.ejcdt.2015.11.006.
   Web of Science ®Google Scholar
• Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. doi:10.1056/NEJMoa0909883.
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Mullerova H, Locantore N, et al. Factors associated with change in exacerbation frequency in COPD. Respir Res. 2013;14(1):79. doi:10.1186/1465-9921-14-79.
   PubMedGoogle Scholar
• Wedzicha JA, Mackay AJ, Singh R. COPD exacerbations: impact and prevention. Breathe. 2013;9(6):434–440. doi:10.1183/20734735.002913.
   Google Scholar
• King PT. Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer. Clin Transl Med. 2015;4(26). doi:10.1186/s40169-015-0068-z.
   PubMedGoogle Scholar
• Fischer MJ, Scharloo M, Abbink JJ, et al. Drop-out and attendance in pulmonary rehabilitation: the role of clinical and psychosocial variables. Respir Med. 2009;103(10):1564–1571. doi:10.1016/j.rmed.2008.11.020.
   PubMed Web of Science ®Google Scholar
• Bohn I, Huber dos Santos Á, Costa CC, et al. Pulmonary rehabilitation in COPD exacerbator phenotype [abstract]. Eur Respir J. 2017;50(Suppl 61):PA760. doi:10.1183/1393003.congress-2017.PA760.
   Google Scholar
• Zanini A, Chetta A, Gumiero F, et al. Six-minute walking distance improvement after pulmonary rehabilitation is associated with baseline lung function in complex COPD patients: a retrospective study. Biomed Res Int. 2013; 2013:1–6. doi:10.1155/2013/483162.
   Web of Science ®Google Scholar
• Moore E, Palmer T, Newson R, et al. Pulmonary rehabilitation as a mechanism to reduce hospitalizations for acute exacerbations of COPD: a systematic review and meta-analysis. Chest. 2016;150(4):837–859. doi:10.1016/j.chest.2016.05.038.
   PubMed Web of Science ®Google Scholar
• Evans RA, Steiner MC. Pulmonary rehabilitation: the lead singer of COPD therapy but not a “one-man band”. Chest. 2017;152(6):1103–1105.
   PubMed Web of Science ®Google Scholar
• Jenkins AR, Gowler H, Curtis F, et al. Efficacy of supervised maintenance exercise following pulmonary rehabilitation on health care use: a systematic review and meta-analysis. COPD. 2018;13:257–273. doi:10.2147/COPD.S150650.
   Google Scholar
• Jenkins AR, Holden NS, Jones AW. Pulmonary Rehabilitation, Exercise, and Exacerbations of COPD: Known Clinical Efficacy and the Unknown Mechanisms. Chest. 2018;153(5):1281–1282. doi:10.1016/j.chest.2018.01.054.
   PubMed Web of Science ®Google Scholar
• Woods JA, Wilund KR, Martin SA, et al. Exercise, inflammation and aging. Aging Dis. 2012;3(1):130–140.
   PubMed Web of Science ®Google Scholar
• Giannopoulou I, Fernhall B, Carhart R, et al. Effetcs of diet and/or exercise on the adipocytokine and inflammatory cytokine levels of postmenopausal women with type 2 diabetes. Metabolism. 2005;54(7):866–875. doi:10.1016/j.metabol.2005.01.033.
   PubMed Web of Science ®Google Scholar
• Takahashi M, Miyashita M, Kawanishi N, et al. Low-volume exercise training attenuates oxidative stress and neutrophils activation in older adults. Eur J Appl Physiol. 2013;113(5):1117–1126. doi:10.1007/s00421-012-2531-5.
   PubMed Web of Science ®Google Scholar
• Canavan J, Garrod R, Marshall J, et al. Measurement of the acute inflammatory response to walking exercise in COPD: effects of pulmonary rehabilitation. Int J COPD. 2007;2:347–353.
   Google Scholar
• Sciriha A, Lungaro-Mifsud S, Bonello A, et al. Systemic inflammation in COPD is not influenced by pulmonary rehabilitation. Eur J Physiother. 2017;19(4):194–200. doi:10.1080/21679169.2017.1332682.
   Web of Science ®Google Scholar
• Silva BSA, Lira FS, Rossi FE, et al. Inflammatory and metabolic responses to different resistance training on chronic obstructive pulmonary disease: a randomized control trial. Front Physiol. 2018;9(262). doi:10.3389/fphys.2018.00262.
   Google Scholar
• Duvoix A, Dickens J, Haq I, et al. Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease. Thorax. 2013;68(7):670–676. doi:10.1136/thoraxjnl-2012-201871.
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106(2):196–204. doi:10.7326/0003-4819-106-2-196.
   PubMed Web of Science ®Google Scholar
• Boutou AK, Tanner RJ, Lord VM, et al. An evaluation of factors associated with completion and benefit from pulmonary rehabilitation in COPD. BMJ Open Resp Res. 2014;1(1):e000051. doi:10.1136/bmjresp-2014-000051.
   PubMedGoogle Scholar
• Department of Health and Social Care. 2012. COPD commissioning toolkit. Available from: https://www.gov.uk/government/publications/commissioning-toolkit-for-respiratory-services.
   Google Scholar
• Steiner M, McMillan V, Lowe D, et al. Pulmonary rehabilitation: beyond breathing better. National Chronic Obstructive Pulmonary Disease (COPD) audit programme: outcomes from the clinical audit of pulmonary rehabilitation services in England 2015. National supplementary report. London: RCP; 2017.
   Google Scholar
• Cecins N, Geelhoed E, Jenkins SC. Reduction in hospitalisation following pulmonary rehabilitation in patients with COPD. Aust Health Review. 2008;32(3):415–422. doi:10.1071/AH080415.
   PubMed Web of Science ®Google Scholar
• Keating A, Lee A, Holland AE. What prevents people with chronic obstructive pulmonary disease from attending pulmonary rehabilitation? A systematic review. Chron Respir Dis. 2011;8(2):89–99. doi:10.1177/1479972310393756.
   PubMed Web of Science ®Google Scholar
• Hayton C, Clark A, Olive S, et al. Barriers to pulmonary rehabilitation: characteristics that predict patient attendance and adherence. Respir Med. 2013;107(3):401–407. doi:10.1016/j.rmed.2012.11.016.
   PubMed Web of Science ®Google Scholar
• Jones SE, Green SA, Clark AL, et al. Pulmonary rehabilitation following hospitalisation for acute exacerbation of COPD: referrals, uptake and adherence. Thorax. 2014;69(2):181–182. doi:10.1136/thoraxjnl-2013-204227.
   PubMed Web of Science ®Google Scholar
• Vanfleteren L, Boonen LMC, Spruit MA, et al. The superexacerbator phenotype in patients with COPD: a descriptive analysis. ERJ Open Res. 2019;5(2):00235-2018. doi:10.1183/23120541.00235-2018.
   PubMedGoogle Scholar
• Le Rouzic O, Roche N, Cortot AB, et al. Defining the “Frequent Exacerbator” phenotype in COPD. Chest. 2018;153(5):1106–1115. doi:10.1016/j.chest.2017.10.009.
   PubMed Web of Science ®Google Scholar
• McCarthy B, Casey D, Devane D, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;23:CD003793.
   Google Scholar
• Chen YW, Leung JM, Sin DD. A systematic review of diagnostic biomarkers of COPD exacerbation. PloS One. 2016;11(7):e0158843. doi:10.1371/journal.pone.0158843.
   PubMed Web of Science ®Google Scholar
• Morano M, Mesquita R, Da Silva GPF, et al. Comparison of the effects of pulmonary rehabilitation with chest physical therapy on the levels of fibrinogen and albumin in patients with lung cancer awaiting lung resection: a randomized clinical trial. BMC Pulm Med. 2014;14(1):121. doi:10.1186/1471-2466-14-121.
   PubMedGoogle Scholar
• Wang S, Liu J, Wu DI, et al. Pro-inflammatory effect of fibrinogen on vascular smooth muscle cells by regulating the expression of PPARα, PPARγ and MMP-9. Biomed Rep. 2015;3(4):513–518. doi:10.3892/br.2015.459.
   PubMed Web of Science ®Google Scholar
• Gammal AIE, O’Farrell R, O’Mahony L, et al. Systemic inflammatory markers and disease severity in chronic obstructive pulmonary disease - the effect of acute exercise and pulmonary rehabilitation. OJRD. 2015;05(01):19–31. doi:10.4236/ojrd.2015.51003.
   Google Scholar
• Oudijk EJ, Nijhuis EH, Zwank MD, et al. Systemic inflammation in COPD visualised by gene profiling in peripheral blood neutrophils. Thorax. 2005;60(7):538–544. doi:10.1136/thx.2004.034009.
   PubMed Web of Science ®Google Scholar
• Ley K, Laudanna C, Cybulsky MI, et al. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007;7(9):678–689. doi:10.1038/nri2156.
   PubMed Web of Science ®Google Scholar
• Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood. 1997;89(10):3503–3521. doi:10.1182/blood.V89.10.3503.
   PubMed Web of Science ®Google Scholar
• Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol. 2006;6(3):173–182. doi:10.1038/nri1785.
   PubMed Web of Science ®Google Scholar
• Wittmann S, Rothe G, Schmitz G, et al. Cytokine upregulation of surface antigens correlates to the priming of the neutrophil oxidative burst response. Cytometry. 2004;57A(1):53–62. doi:10.1002/cyto.a.10108.
   Google Scholar
• Cortjens B, Ingelse SA, Calis JC, et al. Neutrophil subset responses in infants with severe viral respiratory infection. J Clin Immunol. 2017;176:100–106. doi:10.1016/j.clim.2016.12.012.
   Google Scholar
• Steiner MC, Lowe D, Beckford K, et al. Socioeconomic deprivation and the outcome of pulmonary rehabilitation in England and Wales. Thorax. 2017;72(6):530–537. doi:10.1136/thoraxjnl-2016-209376.
   PubMed Web of Science ®Google Scholar
• Maddocks M, Kon SSC, Canavan JL, et al. Physical frailty and pulmonary rehabilitation in COPD: a prospective cohort study. Thorax. 2016;71(11):988–995. doi:10.1136/thoraxjnl-2016-208460.
   PubMed Web of Science ®Google Scholar
• Lee J, Taneja V, Vassallo R. Cigarette smoking and inflammation: cellular and molecular mechanisms. J Dent Res. 2012;91(2):142–149. doi:10.1177/0022034511421200.
   PubMed Web of Science ®Google Scholar
• Jones AW, Taylor A, Gowler H, et al. Systematic review of interventions to improve patient uptake and completion of pulmonary rehabilitation in COPD. ERJ Open Res. 2017;3(1):00089-2016. doi:10.1183/23120541.00089-2016.
   PubMedGoogle Scholar